Uncovering bidirectional brain-body interactions in health and disease

[1]  F. D. De Felice,et al.  Inflammation at the crossroads of COVID-19, cognitive deficits and depression , 2022, Neuropharmacology.

[2]  L. Velloso,et al.  The timeline of neuronal and glial alterations in experimental obesity , 2022, Neuropharmacology.

[3]  T. Kanai,et al.  Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseases , 2021, Neuropharmacology.

[4]  H. Gurden,et al.  Olfaction in the context of obesity and diabetes: Insights from animal models to humans , 2021, Neuropharmacology.

[5]  M. Vickers.  Early life nutrition and neuroendocrine programming , 2021, Neuropharmacology.

[6]  A. Stranahan.  Visceral adiposity, inflammation, and hippocampal function in obesity , 2021, Neuropharmacology.

[7]  J. Fadel,et al.  Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases , 2021, Neuropharmacology.

[8]  J. Clarke,et al.  SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants , 2021, Neuropharmacology.

[9]  R. A. Miranda,et al.  Can breastfeeding affect the rest of our life? , 2021, Neuropharmacology.

[10]  M. Lourenco,et al.  How does the skeletal muscle communicate with the brain in health and disease? , 2021, Neuropharmacology.

[11]  F. D. Felice,et al.  The crosstalk between brain and periphery: Implications for brain health and disease , 2021, Neuropharmacology.

[12]  C. Knauf,et al.  Interactions between the microbiota and enteric nervous system during gut-brain disorders , 2021, Neuropharmacology.

[13]  R. Seeley,et al.  Signalling from the periphery to the brain that regulates energy homeostasis , 2018, Nature Reviews Neuroscience.

[14]  W. Vale,et al.  The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress , 2006, Dialogues in clinical neuroscience.